SOAT1 and glioma: Moreover, patients bearing STAT1-intermediate glioma have longer disease-specific survival when compared with STAT1-high glioma (p = 0.0023), and shorter disease-specific survival when compared with STAT-low glioma (p = 0.0279) (Figure 7C).